User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

712

Interactions with Platform & by Email *

INTERACTIONS

142

Unique # Participated *

PARTICIPANTS

28

Responses Validated *

VALIDATIONS

12

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Global Market Snapshots.....II-4
A Primer.....II-4
1$100
   Market Outlook.....II-5
Market Scenario.....II-5
1$100
   Impact of Recession on Global CLA Market.....II-6
CLA a Rising Star in the Ingredients Market.....II-6
Manufacturers Walk a Tightrope Between Pricing and Functional Claims.....II-6
Regional Disparity in Usage Leads to Erratic Sales.....II-6
1$100
   Requirements for a Successful CLA Market.....II-7
Scientific Evidence Varies for CLA.....II-7
1$100
   Gaining Legislative Approval Essential for CLA Market Growth.....II-8
CLA Clinical Trials Depicting Weight Control.....II-8
1$100
   Factors Assisting Development of the CLA Market.....II-9
Weight Concerns.....II-9
Table 1: Percentage Breakup of Popular Therapy Areas in Supplements and Functional Foods Ingredients and Market (includes corresponding Graph/Chart).....II-9
Aging Population.....II-9
Increasing Disposable Income.....II-9
1$350
   Growing Interest in Naturals.....II-10
Rising Consumer Awareness.....II-10
Rise in Healthcare Costs and Preventive Treatment.....II-10
Technological Advancements.....II-10
Widening Enduse Applications.....II-10
Favorable Regulatory Environment.....II-10
1$100
   Effective Marketing.....II-11
Clinical Evidence.....II-11
Factors Inhibiting Growth of the CLA Market.....II-11
Regulatory Issues.....II-11
Slow and Insignificant Results.....II-11
Lack of Awareness of Potential Health Benefits.....II-11
Short Life Span of Weight Loss Ingredients.....II-11
1$100
   Wide Availability of Low Standard Supplements.....II-12
Contradictory Clinical Reports Regarding CLA’s Efficacy.....II-12
Consumer Skepticism.....II-12
High Prices.....II-12
1$100
   Weight Loss Supplements Rise in Popularity.....II-13
CLA: A Ray of Hope for the Overweight.....II-13
1$100
   Table 2: Obesity Rates in Major Countries Worldwide (2008): Percentage of Total Population in the US, Mexico, Europe, United Kingdom, Germany, and Finland (includes corresponding Graph/Chart).....II-14
Obesity Reaches Alarming Levels in Developing Countries.....II-14
1$350
   Baby Boomers to Foster Growth in the CLA Market.....II-15
Consumer Look Towards Satiety Weight Management Products.....II-15
CLA Manufactures Target Healthy Overweight.....II-15
1$100
   CLA Acquires Place on the Food Map.....II-16
CLA Catching Up With the LOHAS Trend.....II-16
Obese/Overweight Children: Potential CLA Consumers.....II-16
1$100
   CLA Finds Usage in Sports Nutritional Products.....II-17
Ranchers Turning Back to Grass Diet for Cattle.....II-17
1$100
   Introduction to Conjugated Linoleic Acid.....II-18
Definition of CLA.....II-18
Natural Sources of CLA.....II-18
1$100
   Table 3: Content of CLA in Various Food Sources (includes corresponding Graph/Chart).....II-19

Table 4: Approximate Adult Consumption of CLA from Diet- Intake by Country.....II-19
1$350
   Deficiency of CLA.....II-20
CLA as an Ingredient.....II-20
Production.....II-20
Product Forms.....II-20
Recommended Dosage of CLA.....II-20
Process of Absorption, Distribution, Metabolism and Excretion.....II-20
Absorption and Distribution.....II-20
1$100
   Metabolism.....II-21
Excretion.....II-21
Areas Addressed by CLA.....II-21
Enhances Immune System.....II-21
Reduces Fat.....II-21
Regulates Blood Sugar.....II-21
Checks Hypothyroidism.....II-21
1$100
   Minimizes Carcinogenic Risks.....II-22
Promotes Heart Health.....II-22
Stimulates Weight Loss.....II-22
Prevents Osteoporosis and Joint Cartilage Degeneration.....II-22
Relieves Symptoms of Asthma.....II-22
1$100
   CLA Free From Side Effects.....II-23
Overdose of CLA.....II-23
Distribution Channels for CLA Supplements and Fortified Food Products.....II-23
1$100
   CLA in Dietary Supplements.....II-24
CLA in Functional Foods.....II-24
1$100
   CLA in Animal Nutrition.....II-251$100
   Regional Regulatory Aspects.....II-26
European Union.....II-26
The United States.....II-26
Canada.....II-26
1$100
   Japan.....II-271$100
   Bainbridge & Knight Launch Weight Loss Supplement.....II-28
Vega Nutritionals Launches New Meal Replacement Product.....II-28
Finnmax Total Fit CLA Introduced in Russia.....II-28
Cognis Rolls Out Tonalin CLA.....II-28
LiveGreat Unveils CLA Enriched Chocolate Milk.....II-28
Old Home Foods Introduces US’s First CLA Fortified Yogurt.....II-28
1$100
   ALLMAX Introduces CLA80 FEMME.....II-29
4Life Introduces CLA Fortified BioEFA.....II-29
1$100
   BASF Acquires Cognis Holding GmbH.....II-30
Cognis Receives EFSA’s Approval for Tonalin®.....II-30
Lipid Nutrition Files New Claim Dossier.....II-30
1$100
   EFSA Grants Safety Approval for Clarinol®.....II-31
Cognis Receives Novel Food Approval in China.....II-31
Lipid Nutrition and ChemPoint Ink Distribution Agreement.....II-31
Clarinol™ Receives GRAS Status.....II-31
1$100
   Aiko Natural Products Co., Ltd. (China).....II-32
Cognis (Germany).....II-32
Dalian Innobioactives Co., Ltd (China).....II-32
Jarrow Formulas (US).....II-32
1$100
   Lipid Nutrition (The Netherlands).....II-33
Natures Way (US).....II-33
NOW Foods (US).....II-33
Vitae Caps, S.A. (Spain).....II-33
Zhongshan Unicare Natural Medicine Co. Limited (China).....II-33
1$100
   Table 5: World Recent Past, Current & Future Analysis for Conjugated Linoleic Acid by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-341$350
   Table 6: World 10-Year Perspective for Conjugated Linoleic Acid by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2008, 2011 and 2017 (includes corresponding Graph/Chart).....II-351$350
   A. Market Analysis.....II-36
Major Highlights.....II-36
Outlook.....II-36
Obesity Epidemic in the US.....II-36
1$100
   Table 7: Obesity Rates in the US: Percentage Share of the Total Population in 2008, 2000, 1990, and 1980 (includes corresponding Graph/Chart).....II-37

Table 8: US Obesity Rates (2010): Percentage Share for States- Mississippi, Louisiana, Tennessee, Kentucky, Oklahoma, West Virginia, Alabama, Arkansas, Missouri, South Dakota, Michigan, Indiana, South Carolina, Texas and North Carolina (includes corresponding Graph/Chart).....II-37
1$350
   Weight Control Products Fare Well Amid Grim Economy.....II-38
Table 9: US Market for Weight Control Liquids/ Powders (2010): Percentage Breakdown of Dollar Sales by Distribution Channels - Supermarkets, Drug Stores, and Discount Stores (includes corresponding Graph/Chart).....II-38
Market Flooded with Weight Loss Products – US Leads the Trend.....II-38
1$350
   Table 10: New Weight-Loss Product Launches in the US (2008): Percentage Share as to the Total Beverages, Foods, and Supplements Product Launches (includes corresponding Graph/Chart).....II-39

Table 11: New Weight-Loss Product Launches in Europe (2008): Percentage Share as to the Total Beverages, Foods, and Supplements Product Launches (includes corresponding Graph/Chart).....II-39
CLA Regulatory Scenario.....II-39
1$350
   FDA Alerts Consumers over Harmful Weight Loss Products.....II-40
Product Introductions/Innovations.....II-40
1$100
   Recent Industry Activity.....II-41
Key Players.....II-41
1$100
   B. Market Analytics.....II-42
Table 12: US Recent Past, Current & Future Analysis for Conjugated Linoleic Acid Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-42
1$350
   A. Market Analysis.....II-43
Outlook.....II-43
Regulatory Scenario.....II-43
Product Introductions/Innovations.....II-43
1$100
   B. Market Analytics.....II-44
Table 13: Canadian Recent Past, Current & Future Analysis for Conjugated Linoleic Acid Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-44
1$350
   A. Market Analysis.....II-45
Outlook.....II-45
Obesity Issue in Japan Gaining Ground.....II-45
Regulatory Scenario.....II-45
1$100
   B. Market Analytics.....II-46
Table 14: Japanese Recent Past, Current & Future Analysis for Conjugated Linoleic Acid Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-46
1$350
   A. Market Analysis.....II-47
Outlook.....II-47
Regulatory Scenario in the European Union.....II-47
Recent Industry Activity.....II-47
1$100
   Key Players.....II-481$100
   B. Market Analytics.....II-49
Table 15: European Recent Past, Current & Future Analysis for Conjugated Linoleic Acid by Geographic Region - France, Germany, Italy, UK and Rest of Europe Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-49
1$350
   Table 16: European 10-Year Perspective for Conjugated Linoleic Acid by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe for Years 2008, 2011 and 2017 (includes corresponding Graph/Chart).....II-501$350
   A. Market Analysis.....II-51
Outlook.....II-51
Regulatory Outlook.....II-51
1$100
   B. Market Analytics.....II-52
Table 17: French Recent Past, Current & Future Analysis for Conjugated Linoleic Acid Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-52
1$350
   A. Market Analysis.....II-53
Outlook.....II-53
Health Conscious Consumers Drive Demand for Healthy Foods.....II-53
Product Introductions/Innovations.....II-53
Recent Industry Activity.....II-53
1$100
   Key Players.....II-541$100
   B. Market Analytics.....II-55
Table 18: Germany Recent Past, Current & Future Analysis for Conjugated Linoleic Acid Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-55
1$350
   A. Market Analysis.....II-56
Outlook.....II-56
B. Market Analytics.....II-56
Table 19: Italian Recent Past, Current & Future Analysis for Conjugated Linoleic Acid Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-56
1$350
   A. Market Analysis.....II-57
Outlook.....II-57
Product Introductions/Innovations.....II-57
1$100
   B. Market Analytics.....II-58
Table 20: UK Recent Past, Current & Future Analysis for Conjugated Linoleic Acid Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-58
1$350
   A. Market Analysis.....II-59
Outlook.....II-59
B. Market Analytics.....II-59
Table 21: Rest of Europe Recent Past, Current & Future Analysis for Conjugated Linoleic Acid Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-59
1$350
   A. Market Analysis.....II-60
Outlook.....II-60
Obesity: The New Plague in Asia-Pacific.....II-60
Table 22: Percentage of Overweight Men and Women in Select Asian Countries (2005 & 2010) (includes corresponding Graph/Chart).....II-60
1$350
   China –Worrying Trends of Rising Obesity.....II-61
Product Introductions/Innovations.....II-61
Recent Industry Activity.....II-61
Key Players.....II-61
2$125
   B. Market Analytics.....II-63
Table 23: Asia Pacific Recent Past, Current & Future Analysis for Conjugated Linoleic Acid Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-63
1$350
   A. Market Analysis.....II-64
Outlook.....II-64
Obesity: A Growing Crisis in Saudi Arabia.....II-64
1$100
   B. Market Analytics.....II-65
Table 24: Rest of World Recent Past, Current & Future Analysis for Conjugated Linoleic Acid Independently Analyzed with Annual Sales Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart).....II-65
1$350
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com